167 related articles for article (PubMed ID: 32730664)
1. Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood-based fibrosis markers in patients with chronic liver disease.
Jayaswal ANA; Levick C; Selvaraj EA; Dennis A; Booth JC; Collier J; Cobbold J; Tunnicliffe EM; Kelly M; Barnes E; Neubauer S; Banerjee R; Pavlides M
Liver Int; 2020 Dec; 40(12):3071-3082. PubMed ID: 32730664
[TBL] [Abstract][Full Text] [Related]
2. Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease.
Petta S; Sebastiani G; Viganò M; Ampuero J; Wai-Sun Wong V; Boursier J; Berzigotti A; Bugianesi E; Fracanzani AL; Cammà C; Enea M; Grottes MD; Di Marco V; Younes R; Keyrouz A; Mazzola S; Mendoza Y; Pennisi G; Romero-Gomez M; Craxì A; de Ledinghen V
Clin Gastroenterol Hepatol; 2021 Apr; 19(4):806-815.e5. PubMed ID: 32621970
[TBL] [Abstract][Full Text] [Related]
3. Occult cirrhosis diagnosed by transient elastography is a frequent and under-monitored clinical entity.
Chen T; Wong R; Wong P; Rollet-Kurhajec KC; Alshaalan R; Deschenes M; Ghali P; Sebastiani G
Liver Int; 2015 Oct; 35(10):2285-93. PubMed ID: 25676459
[TBL] [Abstract][Full Text] [Related]
4. MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study.
Han MAT; Vipani A; Noureddin N; Ramirez K; Gornbein J; Saouaf R; Baniesh N; Cummings-John O; Okubote T; Setiawan VW; Rotman Y; Loomba R; Alkhouri N; Noureddin M
Liver Int; 2020 Sep; 40(9):2242-2251. PubMed ID: 32652744
[TBL] [Abstract][Full Text] [Related]
5. Role of magnetic resonance elastography in compensated and decompensated liver disease.
Asrani SK; Talwalkar JA; Kamath PS; Shah VH; Saracino G; Jennings L; Gross JB; Venkatesh S; Ehman RL
J Hepatol; 2014 May; 60(5):934-9. PubMed ID: 24362072
[TBL] [Abstract][Full Text] [Related]
6. Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease.
Lin H; Lee HW; Yip TC; Tsochatzis E; Petta S; Bugianesi E; Yoneda M; Zheng MH; Hagström H; Boursier J; Calleja JL; Goh GB; Chan WK; Gallego-Durán R; Sanyal AJ; de Lédinghen V; Newsome PN; Fan JG; Castéra L; Lai M; Harrison SA; Fournier-Poizat C; Wong GL; Pennisi G; Armandi A; Nakajima A; Liu WY; Shang Y; de Saint-Loup M; Llop E; Teh KK; Lara-Romero C; Asgharpour A; Mahgoub S; Chan MS; Canivet CM; Romero-Gomez M; Kim SU; Wong VW;
JAMA; 2024 Apr; 331(15):1287-1297. PubMed ID: 38512249
[TBL] [Abstract][Full Text] [Related]
7. Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease.
Rasmussen DN; Thiele M; Johansen S; Kjærgaard M; Lindvig KP; Israelsen M; Antonsen S; Detlefsen S; Krag A; ;
J Hepatol; 2021 Nov; 75(5):1017-1025. PubMed ID: 34118335
[TBL] [Abstract][Full Text] [Related]
8. Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®).
Poynard T; Vergniol J; Ngo Y; Foucher J; Munteanu M; Merrouche W; Colombo M; Thibault V; Schiff E; Brass CA; Albrecht JK; Rudler M; Deckmyn O; Lebray P; Thabut D; Ratziu V; de Ledinghen V; ; ;
J Hepatol; 2014 Apr; 60(4):706-14. PubMed ID: 24291240
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging metrics and the predictability of adverse outcomes in on-treatment Asian chronic hepatitis B.
Hui RW; Chiu KW; Mak LY; Chang HC; Cheung KS; Fung J; Yuen MF; Seto WK
J Gastroenterol Hepatol; 2022 Jun; 37(6):1139-1147. PubMed ID: 35368120
[TBL] [Abstract][Full Text] [Related]
10. Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort.
Imajo K; Tetlow L; Dennis A; Shumbayawonda E; Mouchti S; Kendall TJ; Fryer E; Yamanaka S; Honda Y; Kessoku T; Ogawa Y; Yoneda M; Saito S; Kelly C; Kelly MD; Banerjee R; Nakajima A
World J Gastroenterol; 2021 Feb; 27(7):609-623. PubMed ID: 33642832
[TBL] [Abstract][Full Text] [Related]
11. Performance of magnetic resonance elastography in primary sclerosing cholangitis.
Eaton JE; Dzyubak B; Venkatesh SK; Smyrk TC; Gores GJ; Ehman RL; LaRusso NF; Gossard AA; Lazaridis KN
J Gastroenterol Hepatol; 2016 Jun; 31(6):1184-90. PubMed ID: 26691631
[TBL] [Abstract][Full Text] [Related]
12. Changes in Liver Stiffness, Measured by Magnetic Resonance Elastography, Associated With Hepatic Decompensation in Patients With Primary Sclerosing Cholangitis.
Eaton JE; Sen A; Hoodeshenas S; Schleck CD; Harmsen WS; Gores GJ; LaRusso NF; Gossard AA; Lazaridis KN; Venkatesh SK
Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1576-1583.e1. PubMed ID: 31683058
[TBL] [Abstract][Full Text] [Related]
13. Prognostic relevance of ARFI elastography in comparison to liver histology and the FIB-4 score.
Klüppel M; Adler W; Schellhaas B; Jesper D; Neurath MF; Pfeifer L
Ultraschall Med; 2024 Jun; 45(3):316-322. PubMed ID: 38171381
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance elastography and proton density fat fraction predict adverse outcomes in hepatocellular carcinoma.
Hui RW; Chan AC; Lo G; Lo R; Chan C; Kotewall CN; Mak LY; She WH; Au KP; Ai V; Fung J; Yuen MF; Seto WK
Hepatol Int; 2022 Apr; 16(2):371-380. PubMed ID: 35347596
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study.
McDonald N; Eddowes PJ; Hodson J; Semple SIK; Davies NP; Kelly CJ; Kin S; Phillips M; Herlihy AH; Kendall TJ; Brown RM; Neil DAH; Hübscher SG; Hirschfield GM; Fallowfield JA
Sci Rep; 2018 Jun; 8(1):9189. PubMed ID: 29907829
[TBL] [Abstract][Full Text] [Related]
16. [Transient elastography as a predictor of oesophageal varices in patients with liver cirrhosis].
Pár G; Trosits A; Pakodi F; Szabó I; Czimmer J; Illés A; Gódi S; Bajor J; Sarlós P; Kenyeres P; Miseta A; Vincze A; Pár A
Orv Hetil; 2014 Feb; 155(7):270-6. PubMed ID: 24509356
[TBL] [Abstract][Full Text] [Related]
17. Elastography-based screening for esophageal varices in patients with advanced chronic liver disease.
Paternostro R; Reiberger T; Bucsics T
World J Gastroenterol; 2019 Jan; 25(3):308-329. PubMed ID: 30686900
[TBL] [Abstract][Full Text] [Related]
18. Spleen stiffness measurement using Fibroscan for the noninvasive assessment of esophageal varices in liver cirrhosis patients.
Stefanescu H; Grigorescu M; Lupsor M; Procopet B; Maniu A; Badea R
J Gastroenterol Hepatol; 2011 Jan; 26(1):164-70. PubMed ID: 21175810
[TBL] [Abstract][Full Text] [Related]
19. Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis.
Malik R; Lai M; Sadiq A; Farnan R; Mehta S; Nasser I; Challies T; Schuppan D; Afdhal N
J Gastroenterol Hepatol; 2010 Sep; 25(9):1562-8. PubMed ID: 20796156
[TBL] [Abstract][Full Text] [Related]
20. Real-time two-dimensional shear wave ultrasound elastography of the liver is a reliable predictor of clinical outcomes and the presence of esophageal varices in patients with compensated liver cirrhosis.
Grgurević I; Bokun T; Mustapić S; Trkulja V; Heinzl R; Banić M; Puljiz Ž; Lukšić B; Kujundžić M
Croat Med J; 2015 Oct; 56(5):470-81. PubMed ID: 26526884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
